Indy (317) 643-4444 Fishers (317) 567-9100
Semaglutide Novo Nordisk

Ozempic®

The Original Semaglutide That Started It All

Ozempic® (semaglutide) is FDA-approved for type 2 diabetes and widely prescribed for weight loss. The medication that sparked the GLP-1 weight loss revolution.

Regulates appetite
Balances blood sugar
Reduces cravings
Get Started Learn more
14-15% average weight loss
Once Weekly Injection
$175 Per month
Save 82% vs. ~$950 retail
Basics Benefits How It Works Safety FAQ

What is Ozempic?

Ozempic made headlines as the medication that introduced millions to the power of GLP-1 therapy. While FDA-approved for diabetes, its remarkable weight loss effects have made it one of the most prescribed medications for off-label weight management.

Clinical Trial Results

In the SUSTAIN trials, patients taking the highest Ozempic dose (2mg) lost an average of 14-15% of their body weight as a secondary benefit while treating diabetes.

FDA Approved For

  • Type 2 diabetes as adjunct to diet and exercise
  • Reduction of cardiovascular events in adults with type 2 diabetes and established cardiovascular disease
  • Weight loss (off-label but widely prescribed)

Quick Facts

Generic Name
Semaglutide
Manufacturer
Novo Nordisk
Drug Class
GLP-1 Receptor Agonist
Administration
Subcutaneous injection
Frequency
Once Weekly

Benefits of Ozempic

1

Well-established safety and efficacy profile

2

Significant 14-15% average weight loss

3

Excellent blood sugar control for diabetics

4

Once-weekly injection convenience

5

Cardiovascular protection

6

Most affordable GLP-1 option

7

Years of real-world usage data

8

Often available when newer medications face shortages

How Ozempic Works

Ozempic contains semaglutide, which mimics your body's natural GLP-1 hormone. It reduces appetite by acting on hunger centers in the brain, slows stomach emptying so you feel full longer, and improves blood sugar control. This triple action makes it highly effective for both diabetes and weight loss.

Ideal Candidates

  • Adults with type 2 diabetes seeking weight loss
  • Patients wanting the most affordable GLP-1 option
  • Those who prefer a well-established medication with long track record
  • Adults with BMI ≥27-30 starting their weight loss journey
  • Patients with cardiovascular disease wanting heart protection

Not Recommended For

  • Personal or family history of medullary thyroid carcinoma
  • Multiple Endocrine Neoplasia syndrome type 2
  • Pregnancy or planning to become pregnant
  • Breastfeeding
  • Type 1 diabetes
  • History of severe pancreatitis

Safety Information

Black Box Warning

Semaglutide causes thyroid C-cell tumors in rodents at clinically relevant exposures. It is unknown whether Ozempic causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. Ozempic is contraindicated in patients with a personal or family history of MTC or in patients with MEN 2.

Common Side Effects

Most side effects improve as your body adjusts to the medication.

  • Nausea ~20%
  • Vomiting ~9%
  • Diarrhea ~9%
  • Constipation ~5%
  • Abdominal pain ~7%

Serious Side Effects

Rare but important. Contact your provider if you experience any of these.

  • Pancreatitis - seek care for severe abdominal pain
  • Diabetic retinopathy changes - monitor if you have existing eye disease
  • Kidney problems - especially with dehydration
  • Hypoglycemia - mainly when combined with insulin
  • Allergic reactions - rare but require immediate attention

Frequently Asked Questions

Yes! While Ozempic is FDA-approved for diabetes, physicians can legally prescribe it off-label for weight loss. At Premier Weight Loss, we evaluate your health profile and prescribe the most appropriate medication for your needs.

Ozempic is often more available during shortages, is our most affordable option at $175/month, and may be sufficient for patients seeking moderate weight loss (14-15%). Wegovy goes to a higher dose and may produce slightly more weight loss.

Ozempic (semaglutide) works on one receptor (GLP-1), while Mounjaro (tirzepatide) works on two (GIP + GLP-1). Mounjaro typically produces more weight loss (20-22% vs 14-15%) but costs more. Many patients start with Ozempic and switch if needed.

Supply has improved significantly. At Premier Weight Loss, we work with multiple pharmacies and compounding sources to maintain consistent access for our patients. We'll always communicate proactively about any supply issues.

You'll likely notice reduced appetite within 1-2 weeks. Weight loss typically becomes visible by weeks 4-6 and continues for months as your dose is optimized. Most patients see their best results between months 6-12.

Compare Medications

Tirzepatide

Mounjaro®

20-22% $275/mo
Learn more Tirzepatide

Zepbound®

20-22% $275/mo
Learn more Semaglutide

Wegovy®

15-17% $175/mo
Learn more
Compare All Medications

Ready to Start Ozempic?

Take our quick eligibility quiz or schedule a consultation with our medical team.

Check If You Qualify
Indianapolis (317) 643-4444Fishers (317) 567-9100